back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-09 18:10 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
1,104,320 | |
| Filed 2023-05-09 18:09 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
| Filed 2023-05-09 18:08 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
| Filed 2023-05-09 18:08 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
||
| Filed 2023-05-09 14:30 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
||
| Filed 2023-05-09 14:30 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
1,104,320 | |
| Filed 2023-05-09 14:29 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
| Filed 2023-05-09 14:29 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
| Filed 2023-05-09 14:28 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-23 11:19 Tx date 2022-06-15 |
$ENER
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,013,200 | ||
| Filed 2022-06-23 11:19 Tx date 2022-06-15 |
$ENER
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|